Suppr超能文献

在地塞米松抑制试验期间,健康犬、患有肾上腺皮质功能亢进的犬以及患有非肾上腺疾病的犬体内地塞米松的循环浓度。

Circulating concentration of dexamethasone in healthy dogs, dogs with hyperadrenocorticism, and dogs with nonadrenal illness during dexamethasone suppression testing.

作者信息

Kemppainen R J, Peterson M E

机构信息

Department of Physiology and Pharmacology, Auburn University College of Veterinary Medicine, Auburn University, AL 36849.

出版信息

Am J Vet Res. 1993 Oct;54(10):1765-9.

PMID:8250405
Abstract

Concentration of dexamethasone was determined in plasma or serum samples from dogs after i.v. administration of a low dose (0.01 mg/kg of body weight) or high dose (0.1 mg/kg) of dexamethasone. On the basis of history, clinical signs of disease, and degree of cortisol suppression in response to dexamethasone, dogs were assigned to these groups: healthy dogs, dogs with nonadrenal illness, and dogs with hyperadrenocorticism. Four hours after administration of the low dose of dexamethasone, concentration of the steroid was reduced (P < 0.05) in dogs with hyperadrenocorticism, compared with healthy dogs, but not compared with values from dogs with nonadrenal illness. By 8 hours after dexamethasone administration, values were similar across groups. Dexamethasone concentration 4 and 8 hours after high-dose administration was similar between healthy dogs and dogs with hyperadrenocorticism. Concentration of dexamethasone 4 and 8 hours after its administration overlapped after the 2 doses. For example, in 11 of 66 dogs from all groups, concentration measured 4 hours after the low dose was greater than the minimal concentration determined in the 18 dogs given the high dose. These data indicate that dexamethasone metabolism may be altered in dogs with hyperadrenocorticism, and that individuals may have appreciable variability in dexamethasone clearance. Such variability provides a possible explanation for false-positive and false-negative results associated with dexamethasone suppression testing in dogs.

摘要

静脉注射低剂量(0.01毫克/千克体重)或高剂量(0.1毫克/千克)地塞米松后,测定犬血浆或血清样本中地塞米松的浓度。根据病史、疾病临床症状以及对地塞米松反应的皮质醇抑制程度,将犬分为以下几组:健康犬、患有非肾上腺疾病的犬和患有肾上腺皮质功能亢进的犬。静脉注射低剂量地塞米松4小时后,与健康犬相比,患有肾上腺皮质功能亢进的犬体内类固醇浓度降低(P < 0.05),但与患有非肾上腺疾病的犬的值相比无差异。地塞米松给药后8小时,各组的值相似。高剂量给药后4小时和8小时,健康犬和患有肾上腺皮质功能亢进的犬体内地塞米松浓度相似。两次给药后4小时和8小时地塞米松浓度存在重叠。例如,在所有组的66只犬中,有11只犬在低剂量给药后4小时测得的浓度高于给予高剂量的18只犬中测定的最低浓度。这些数据表明,患有肾上腺皮质功能亢进的犬地塞米松代谢可能发生改变,而且个体在地塞米松清除方面可能存在明显差异。这种差异为犬地塞米松抑制试验相关的假阳性和假阴性结果提供了一种可能的解释。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验